Previously, Brown et al. observed somatic variants affecting NRAS, SRSF2, DNMT3A and other genes associated with epigenetic regulation in RUNX1-FPD patients with AML [36]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.